(i) Bachelor's Degree in Pharmacy from Curtin University of Technology, Western Australia (previously known as Western Australian Institute of Technology (WAIT)) (1977)

(ii) Diploma (Postgradute) in Medical Microbiology, Institute for Medical Research, Kuala Lumpur (1983)

(iii) Master of Science in Pharmaceutical Analysis, University of Manchester, United Kingdom (1986)

Dato' Eisah served in the Malaysian Ministry of Health as a pharmacist since 1979 and held several key positions throughout her years of service. This included being the Head of Pharmaceutical Microbiology Lab, Head of GMP and Licensing Section, Deputy Director of Centre for Product Registration and eventually becoming the Director of NPCB. In 2007, she was made Director of Pharmacy Enforcement and was promoted to Senior Director of Pharmaceutical Services in 200, taking charge of the entire pharmacy program in Malaysia. Also, since 2008, she was the Registrar of the Pharmacy Board of Malaysia. Throughout her career, she made significant contributions to the pharmacy service and the pharmaceutical sector. She was involved in various national high level committees such as the Ministry of Health's Steering Committee for National Medicines Policy. She  participated in healthcare related conferences serving as an expert on regulatory matters. She has presented major papers on regulatory control locally and internationally. Internationally, she has held advisory roles in the area of regulations and pharmaceutical quality assurance. She was also involved in the ASEAN harmonisation initiatives for pharmaceuticals (medical devices, cosmetics, traditional medicines and health supplements). She chaired the ASEAN Consultative Committee for Standards and Quality (ACCSQ) Pharmaceutical Product Working Group, which was instrumental to the implementation of the ASEAN Common Technical Dossier and the ASEAN Technical Guidelines. She led NPCB to being accepted as the 26th Member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) in 2002. Under her leadership, NPCB was designated a Non-OECD Member Adhering to the OECD Mutual Acceptance Data (OECD-MAD) System. Also under her helm, the Pharmaceutical Services Division received the Global Anti-Counterfeiting Anti-Counterfeiting Award 2013 and the Special Innovation Award 2013 for initiatives in combatting counterfeit medicines.

NIL

NIL

NIL

NIL